🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this Phase-2 chronic weight management master protocol (CWMM...
Status
Recruiting
Location
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Start Date
2023-11-17
Trial ID
NCT06143956
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Completed
Location
Covance Dallas
Start Date
2021-02-22
Trial ID
NCT04758234
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Terminated
Location
Headlands Research - Scottsdale
Start Date
2025-07-21
Trial ID
NCT07085468
The main purpose of this study is to investigate LY3549492 in Chinese parti...
Status
Completed
Location
Peking University People's Hospital
Start Date
2025-07-25
Trial ID
NCT07073170
The main purpose of this study is to measure how much of the study drug get...
Status
Completed
Location
Fortrea Clinical Research Unit
Start Date
2024-01-03
Trial ID
NCT06194500
Treatments Being Tested
The purpose of this study is to evaluate how well LY3549492 is tolerated an...
Status
Completed
Location
Hakata Clinic
Start Date
2025-05-07
Trial ID
NCT06869018
The purpose of this study is to see how safe and well-tolerated the drug LY...
Status
Completed
Location
Fortrea Clinical Research Unit
Start Date
2025-10-27
Trial ID
NCT07232732
Treatments Being Tested
The main purpose of this study, performed under the master protocol W8M-MC-...
Status
Completed
Location
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Start Date
2024-11-13
Trial ID
NCT06683508
The main purpose of this study, performed under the master protocol W8M-MC-...
Status
Terminated
Location
HOPE Research Institute
Start Date
2025-06-19
Trial ID
NCT07030868
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Completed
Location
Profil Institut für Stoffwechselforschung
Start Date
2022-05-09
Trial ID
NCT05327595
Treatments Being Tested